These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 3924048)

  • 21. Characterization of Trypanosoma brucei brucei S-adenosyl-L-methionine decarboxylase and its inhibition by Berenil, pentamidine and methylglyoxal bis(guanylhydrazone).
    Bitonti AJ; Dumont JA; McCann PP
    Biochem J; 1986 Aug; 237(3):685-9. PubMed ID: 3800910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosoma brucei brucei: characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine.
    Li F; Hua SB; Wang CC; Gottesdiener KM
    Exp Parasitol; 1998 Mar; 88(3):255-7. PubMed ID: 9562432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D,L-alpha-difluoromethylornithine.
    Iten M; Mett H; Evans A; Enyaru JC; Brun R; Kaminsky R
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1922-5. PubMed ID: 9303385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.
    Klee N; Wong PE; Baragaña B; Mazouni FE; Phillips MA; Barrett MP; Gilbert IH
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4364-6. PubMed ID: 20615694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of alpha-difluoromethylornithine inhibition of caerulein-induced pancreatic growth by putrescine.
    Morisset J; Benrezzak O
    Regul Pept; 1985 Jul; 11(3):201-8. PubMed ID: 3933061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between 9-deazainosine and DL-alpha-difluoromethylornithine in treatment of experimental African trypanosomiasis.
    Bacchi CJ; Berens RL; Nathan HC; Klein RS; Elegbe IA; Rao KV; McCann PP; Marr JJ
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1406-13. PubMed ID: 3118799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel combination chemotherapy of experimental trypanosomiasis by using bleomycin and DL-alpha-difluoromethylornithine; reversal by polyamines.
    Bacchi CJ; Nathan HC; Hutner SH; McCann PP; Sjoerdsma A
    Biochem Pharmacol; 1982 Sep; 31(17):2833-6. PubMed ID: 6182888
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of combinations of difluoromethylornithine and bleomycin in a mouse model of central nervous system African trypanosomiasis.
    Clarkson AB; Bacchi CJ; Mellow GH; Nathan HC; McCann PP; Sjoerdsma A
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5729-33. PubMed ID: 6193522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DL-alpha-difluoromethylornithine (DFMO)-Berenil combination: therapeutic and prophylactic activity against Trypanosoma brucei brucei infection in mice.
    Onyeyili PA; Egwu GO; Zaria LT; Orjiude BA
    Rev Elev Med Vet Pays Trop; 1991; 44(4):443-5. PubMed ID: 1843826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of polyamines in isoproterenol-induced cardiac hypertrophy: effects of alpha-difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase.
    Bartolome JV; Trepanier PA; Chait EA; Slotkin TA
    J Mol Cell Cardiol; 1982 Aug; 14(8):461-6. PubMed ID: 6217347
    [No Abstract]   [Full Text] [Related]  

  • 31. Differential susceptibility to DL-alpha-difluoromethylornithine in clinical isolates of Trypanosoma brucei rhodesiense.
    Bacchi CJ; Nathan HC; Livingston T; Valladares G; Saric M; Sayer PD; Njogu AR; Clarkson AB
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1183-8. PubMed ID: 2118325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase.
    Bitonti AJ; Byers TL; Bush TL; Casara PJ; Bacchi CJ; Clarkson AB; McCann PP; Sjoerdsma A
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1485-90. PubMed ID: 1977366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis.
    Barker RH; Liu H; Hirth B; Celatka CA; Fitzpatrick R; Xiang Y; Willert EK; Phillips MA; Kaiser M; Bacchi CJ; Rodriguez A; Yarlett N; Klinger JD; Sybertz E
    Antimicrob Agents Chemother; 2009 May; 53(5):2052-8. PubMed ID: 19289530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning and sequencing of the ornithine decarboxylase gene from Trypanosoma brucei. Implications for enzyme turnover and selective difluoromethylornithine inhibition.
    Phillips MA; Coffino P; Wang CC
    J Biol Chem; 1987 Jun; 262(18):8721-7. PubMed ID: 3036823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trypanosoma brucei brucei: regulation of ornithine decarboxylase in procyclic forms and trypomastigotes.
    Bacchi CJ; Garofalo J; Santana A; Hannan JC; Bitonti AJ; McCann PP
    Exp Parasitol; 1989 May; 68(4):392-402. PubMed ID: 2498115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Trypanosoma brucei bloodstream form mutant deficient in ornithine decarboxylase can protect against wild-type infection in mice.
    Mutomba MC; Li F; Gottesdiener KM; Wang CC
    Exp Parasitol; 1999 Feb; 91(2):176-84. PubMed ID: 9990346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ornithine uptake and the modulation of drug sensitivity in
    Macedo JP; Currier RB; Wirdnam C; Horn D; Alsford S; Rentsch D
    FASEB J; 2017 Oct; 31(10):4649-4660. PubMed ID: 28679527
    [No Abstract]   [Full Text] [Related]  

  • 38. Aminoguanidine reversal of the inhibitory effects of ornithine analogs on the in vitro clonogenic survival of the R3327AT prostate-derived tumor.
    Heston WD; Lazan DW; Fair WR
    Cancer Lett; 1981 Feb; 11(4):323-30. PubMed ID: 6794904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha-(Fluoromethyl)dehydroornithine and alpha-(fluoromethyl)dehydroputrescine analogues as irreversible inhibitors of ornithine decarboxylase.
    Bey P; Gerhart F; Van Dorsselaer V; Danzin C
    J Med Chem; 1983 Nov; 26(11):1551-6. PubMed ID: 6631913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New drug combination for experimental late-stage African trypanosomiasis: DL-alpha-difluoromethylornithine (DFMO) with suramin.
    Clarkson AB; Bienen EJ; Bacchi CJ; McCann PP; Nathan HC; Hutner SH; Sjoerdsma A
    Am J Trop Med Hyg; 1984 Nov; 33(6):1073-7. PubMed ID: 6439061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.